HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

6th Edition of World Congress on Infectious Diseases

June 24-26, 2024 | Paris, France

June 24 -26, 2024 | Paris, France

Infection 2024

Speaker at Infectious Diseases Conferences - Claudia Ferreira
Keynote Presentation (In-Person)
Claudia Ferreira, Biophytis Sorbonne, France

After describing the situation in which the athletes of the XXXIII Olympiad in France in 2024 from 26 July to 11 August, will find themselves namely, the city of Paris, the Seine River, the medical infrastructure, the past experience with SARS, and giving data on hygiene, pathoge [....] » Read More

Speaker at Infectious Diseases Conferences - Prabha Chandrasekaran
Keynote Presentation (In-Person)
Prabha Chandrasekaran, NIAID, National Institutes of Health, United States

In the absence of well-defined correlates of protection, the quantity and duration of the main vaccine-antigen-induced immunoglobulin G (IgG) antibodies are often used as proxy indicators of vaccine efficacy; IgG responses to vaccine vector antigens are less well-characterized. H [....] » Read More

Speaker at Infectious Diseases Conferences - Valerie Pourcher
Oral Presentation (In-Person)
Valerie Pourcher, Pitie Salepetriere Hospital, France

Background: SARS-CoV-2 infects human cells through interaction between its spike protein, and ACE2, a key element of the RAS. Thus  SARS-CoV-2 may induce  an imbalance of the RAS leading, among other symptoms, to severe pneumonia associated with COVID-19. We h [....] » Read More

Speaker at Infection Conference - Petersian M. Alcazaren
Oral Presentation (In-Person)
Petersian M. Alcazaren, West Visayas State University Medical Center, Philippines

Background: COVID-19 is a viral respiratory illness caused by SARS-CoV-2, confirmed with RTPCR testing. Considering the heterogeneity of clinical picture of COVID-19 disease, and the threats of its variants, the review of current clinical data and outcome of available management [....] » Read More

Speaker at Infection Conferences - Cara Spence
Oral Presentation (In-Person)
Cara Spence, University of Saskatchewan, Canada

Context: An alarming increase of infectious and congenital syphilis rates is being seen in Saskatchewan and the prairie provinces of Canada. According to the Public Health Agency of Canada, the national rate of infectious syphilis increased from 5.1 per 100,000 population in 2011 [....] » Read More

Speaker at Infectious Diseases Conferences - Elizabeth Yvonne Flores
Oral Presentation (In-Person)
Elizabeth Yvonne Flores, Boston University School of Medicine, United States

Affected Ebola virus disease (EVD) patients lose copious amounts of fluids in a matter of days, rapidly deteriorating into hypovolemic shock and death. Similar intestinal manifestations were also reported for Marburg virus (MARV) disease, another filovirus. At present, available [....] » Read More

Speaker at Infection Conference - Daniela Tirotta
Oral Presentation (In-Person)
Daniela Tirotta, Morgagni - Pierantoni Hospital in Forlì, Italy

Introduction. Visceral leishmaniasis is an potentially fatal and neglected tropical disease, according to the World Health Organization’s : mortality is still very high ( 95% ) when untreated. This disease presents a broad spectrum of symptoms (oligosymptomatic infection, b [....] » Read More

Speaker at Infection Conferences - Hideliz Marie G Pascua
Oral Presentation (In-Person)
Hideliz Marie G Pascua, Baguio General Hospital and Medical Center, Philippines

Candida duobushaemulonii is a yeast that belongs to the Candida haemulonii species complex. Similar to Candida auris which is an emerging global health threat, C. duobushaemulonii is a major concern in the healthcare system as it is often multidrug resistant. Prese [....] » Read More

Speaker at Infectious Diseases Conferences - Anne Morris
Oral Presentation (In-Person)
Anne Morris, North Bristol NHS Trust, United Kingdom

Background: Vaccination remains one of the most successful public health interventions in preventing severe disease and death. The roll-out of Covid-19 vaccination programmes has helped protect billions of people around the world against Covid-19. Most of these programmes have be [....] » Read More

Speaker at Infection Conference - Petersian M. Alcazaren
Oral Presentation (In-Person)
Petersian M. Alcazaren, West Visayas State University Medical Center, Philippines

Background As the world presently navigates the coronavirus disease 2019 (COVID-19) pandemic, there is a growing need to assess its impact in patients with underlying immunocompromised states, including autoimmune rheumatic diseases, such as systemic lupus erythematosus (SLE), an [....] » Read More

Speaker at Infectious Diseases Conference - Ashley Zhou
Oral Presentation (In-Person)
Ashley Zhou, Mayo Clinic, United States

Skin and soft tissue infections (SSTI) represent an uncommon source of infection (<10%) in patients with persistent or recurring fever and neutropenia.1-3 Worldwide, the prevalence of immunocompromised hosts is increasing even as the incidence of gram-negative and of multidrug [....] » Read More

Speaker at Infectious Diseases Conferences - Nadine Bacalangco Suerte
Oral Presentation (In-Person)
Nadine Bacalangco Suerte, West Visayas State University Medical Center, Philippines

Background: Vaccination across countries against COVID-19 have shown to be effective against infection and mortality in different settings. However, recent data describe breakthrough COVID-19 infection among vaccinated individuals. Risk factors and clinical characteristics have b [....] » Read More

Speaker at Infection Conferences - Silvia Giono Cerezo
Poster Presentation (In-Person)
Silvia Giono Cerezo, Instituto Politecnico Nacional, Mexico

 Acinetobacter baumannii is an opportunistic pathogen responsible for healthcare-associated infections (HAIs) and outbreaks. Antimicrobial resistance mechanisms and virulence factors allow it to survive and spread in the hospital environment. However, the molecular mechanism [....] » Read More

Speaker at Infection Conferences - Eric Brownhill
Poster Presentation (In-Person)
Eric Brownhill, Jacobi Medical Center, United States

Intro: The safety profile of oral iron supplementation is well established and generally benign, but many practitioners limit iron supplementation in patients hospitalized for infectious causes, even in the presence of iron-deficiency anemia (IDA). Nearly all human pathogens requ [....] » Read More

Speaker at Infectious Diseases Conferences - Michele de Leon Jauregui
Poster Presentation (In-Person)
Michele de Leon Jauregui, University of Utah, United States

A 4-day-old term infant with a low EOS risk score originally presented to the ED with six hours of lethargy and poor feeding. Initial work-up was demonstrated acute liver failure (PT/INR 18.5, ALT>90, AST>300), hypoglycemia, hyperferritinemia (ferritin >44,000), severe t [....] » Read More

Speaker at Infectious Diseases Conferences - Eduardo Ferracioli Oda
Poster Presentation (In-Person)
Eduardo Ferracioli Oda, University of Sao Paulo, Brazil

Purpose: To describe the pathogens detected in intraocular fluid of individuals with active uveitis using a low-volume direct multiplex PCR. Methods: Eighty-six individuals with active uveitis were included in this study between July, 21 and November, 23. All participants had [....] » Read More

Speaker at Infection Conference - Renata Karina Reis
Poster Presentation (In-Person)
Renata Karina Reis, University of Sao Paulo, Ribeirao Preto College of Nursing, Brazil

Introduction: The presence of an untreated STI significantly increases the chance of acquiring HIV. In Brazil, CT/NG testing among PrEP users is insufficient and syndromic treatment is a priority in clinical practice. Multi-site testing for CT/NG improves screening of asymptomati [....] » Read More

Speaker at Infection Conference - Renata Karina Reis
Poster Presentation (In-Person)
Renata Karina Reis, University of Sao Paulo, Ribeirao Preto College of Nursing, Brazil

Introduction: Vaccine hesitancy was considered by the World Health Organization as one of the 10 threats to global public health in 2019. In Brazil, the National Immunization Program offers the population vaccines free of charge through the Unified Health System. However, people [....] » Read More

Speaker at Infection Conferences - Kristine Mae D. Barredo
Poster Presentation (In-Person)
Kristine Mae D. Barredo, Zamboanga City Medical Center, Philippines

Introduction: Defining the epidemiological and clinical features of COVID in pediatric patients can aid in the control of spread and improve the curative rate. Objectives: This study determined the epidemiological and clinical characteristics of COVID confirmed children admitt [....] » Read More

Speaker at Infectious Diseases Conferences - Dorarca Lynch
Poster Presentation (In-Person)
Dorarca Lynch, Galway University Hospital, Ireland

Clinical case: We present a case of a 32-year-old Indian gentleman admitted to a tertiary hospital in the West of Ireland Hospital with a weeklong history of fevers and right upper quadrant pain complicated by the development of clinical jaundice.  His past medical history w [....] » Read More

Speaker at Infectious Diseases Conferences - Joo Hee Waelzlein
Poster Presentation (In-Person)
Joo Hee Waelzlein, Robert Koch-Institute, Germany

Our project highlights the critical need for scientific data in assessing the risks posed by emerging and re-emerging viruses, both during endemic and pandemic outbreaks. It emphasizes the importance of validated decontamination procedures and infection control measures with the [....] » Read More

Speaker at Infectious Diseases Conferences - Joo Hee Waelzlein
Poster Presentation (In-Person)
Joo Hee Waelzlein, Robert Koch-Institute, Germany

Background: In recent years, organoids have advanced to prominent and versatile tools in 3R research, representing valuable alternatives for animal models and physiologically relevant human disease models at the same time. As the federal Public Health Institute, the RKI aims to e [....] » Read More

Speaker at Infection Conference - Julia Nowak
Poster Presentation (In-Person)
Julia Nowak, Maynooth University, Ireland

Sepsis is a serious medical condition, and newborns in low- and middle-income countries (LMICs) are particularly vulnerable. Uganda has one of the highest rates of neonatal sepsis deaths in the world at 17 neonatal deaths per day. Such high mortality rates are largely due to the [....] » Read More

Speaker at Infectious Diseases Conferences - Amy Hesketh
Poster Presentation (In-Person)
Amy Hesketh, Bioaster, France

Introduction: Trypanosoma cruzi (T. cruzi) is a protozoan parasite that causes Chagas disease. This zoonotic disease is transmitted to human by blood-sucking triatomine bugs. According to WHO, Chagas disease is affecting 30 000 new cases and is causing 13 000 deaths per year main [....] » Read More

Speaker at Infection Conferences - Alvaro J. Vivas Salinas
Poster Presentation (In-Person)
Alvaro J. Vivas Salinas, Clínica Central del Quindío, Colombia

Introduction: Eczema herpeticum (EH), also known as Kaposi’s varicelliform eruption, is an unusual, severe manifestation of herpes simplex infection. It usually presents in pediatric patients with history of atopic dermatitis. It can be a life-threatening disease with morta [....] » Read More

Speaker at Infectious Diseases Conference - Reem Abdulla AlSaadi
Poster Presentation (In-Person)
Reem Abdulla AlSaadi, Cleveland Clinic Abu Dhabi, United Arab Emirates

Our presentation is about a challenging case of a 28-year-old male, previously healthy and a nonsmoker, from India and working as a security guard. He was referred to our facility for evaluation of disseminated Echinococcus infection affecting the lung and heart, presenting with [....] » Read More

Speaker at Infectious Diseases Conferences - Khalid Muneer Albalushi
Poster Presentation (In-Person)
Khalid Muneer Albalushi, Sultan Qaboos University, Oman

Objectives and rationale: This study aims to investigate the prevalence, demographics, and risks of co-infections among hospitalized patients at Sultan Qaboos University Hospital (SQUH); a tertiary-care hospital in Muscat, Oman. Aim: This study aims to identify the most common [....] » Read More

Speaker at Infectious Diseases Conference - Hatice Turk Dagi
Poster Presentation (In-Person)
Hatice Turk Dagi, Selcuk University, Turkey

Enterococci are gram-positive, facultative anareobic bacteria that are usually found in gastrointestinal tract of humans, animals and environmental sources. Enterococci can lead to severe hospital-acquired infections and are difficult to treat due to their high level of antibioti [....] » Read More

Speaker at Infectious Diseases Conference - Daniel A. Lichtenstein
Keynote Presentation (In-Person)
Daniel A. Lichtenstein, Ambroise Pare Hospital, France

The BLUE-protocol is an ultrasound approach of lungs and veins, allowing with fine accuracies an immediate diagnosis of an acute respiratory failure among the six causes which regard 97% of patients seen in critical settings: hemodynamic pulmonary edema, pulmonary embolism, [....] » Read More

Speaker at Infectious Diseases Conferences - Xiaoyun Zhao
Keynote Presentation (In-Person)
Xiaoyun Zhao, Tianjin University Chest Hospital, China

Purpose: In contemporary epochs, the prevalence of pertussis has been progressively on the rise, persisting as a formidable health concern. The manifestations following pertussis infection lean towards the atypical, making them easily disregarded or subject to misdiagnosis. Our a [....] » Read More

Speaker at Infectious Diseases Conferences - Krzysztof Skowron
Keynote Presentation (Virtual)
Krzysztof Skowron, Nicolaus Copernicus University in Torun, Poland

The increase in the transfer of pathogenic microorganisms between humans, livestock, wildlife and their environment observed in recent years, as well as the irrational use of antibiotics, makes it increasingly difficult to combat the growing multidrug resistance of bacteria such [....] » Read More

Speaker at Infectious Diseases Conferences - Susannah Colt
Oral Presentation (In-Person)
Susannah Colt, Warren Alpert Medical School of Brown University, United States

Background: Children with intestinal schistosomiasis are at risk for undernutrition, anemia, linear growth stunting, and impaired cognitive development. Vitamin A deficiency impairs immune function against parasitic pathogens. In rodents, dietary-induced vitamin A deficiency caus [....] » Read More

Speaker at Infection Conference - Sukki Ho
Oral Presentation (In-Person)
Sukki Ho, The Hong Kong Polytechnic University, Hong Kong

Nasogastric tube (NG tube) feeding in residential care homes for the elderly (RCHEs) carries the risk of contamination at the NG tube hub, a crucial connection point in the enteral feeding process. This contamination can lead to the spread of harmful microorganisms, potentially r [....] » Read More

Speaker at Infectious Diseases Conferences - Julissa Soto
Oral Presentation (In-Person)
Julissa Soto, Julissa Soto Latino Health Equity Consulting, United States

At the onset of the COVID-19 Pandemic, policymakers and public health officials often cited “vaccine hesitancy” as a key challenge to reaching vulnerable populations, including immigrants, Spanish-speaking communities, Latino communities, and others who have been marg [....] » Read More

Speaker at Infectious Diseases Conference - Caroline Ballet
Oral Presentation (In-Person)
Caroline Ballet, Fabentech, France

Successive sub-lineages of Omicron have spread since the occurrence of BA.1 in November 2021. Identified in July 2022, BQ.1 and BQ.1.1 expanded dramatically in Europe and North America. XBB and XBB.1 were first identified in India in mid-August 2022 and quickly spread to become p [....] » Read More

Speaker at Infectious Diseases Conferences - Nouf Alaboud
Oral Presentation (In-Person)
Nouf Alaboud, University College London, United Kingdom

Background: • Sepsis is one of the most common leading causes of death in paediatric patients worldwide. • The WHO has defined sepsis as “a life-threatening organ dysfunction caused by a dysregulated host response to infection” • Early recognition of [....] » Read More

Speaker at Infectious Diseases Conference - Quennie Bien Bien C. Yu
Oral Presentation (In-Person)
Quennie Bien Bien C. Yu, St. Luke's Medical Center- Global City, Philippines

Kluyvera sp., an opportunistic Gram-negative bacillus found in clinical specimens such as sputum, urine, bile, peritoneal fluid, and blood, rarely causes significant infections. This case report manages a rare Kluyvera cryocrescens bacteremia in a female patient with chronic kidn [....] » Read More

Speaker at Infectious Diseases Conferences - Laura Fermiano Bastos
Oral Presentation (In-Person)
Laura Fermiano Bastos, University Center Assis Gurgacz Foundation, Brazil

This article aims to identify the impact of the novel coronavirus pandemic on malaria cases in the North, Northeast, Midwest, Southeast, and South regions of Brazil, given the similarity of initial symptoms, the need for reallocation of resources, and the burden on public health [....] » Read More

Speaker at Infectious Diseases Conference - Ahmed Esam Mahboub
Oral Presentation (In-Person)
Ahmed Esam Mahboub, Tawam Hospital, United Arab Emirates

Introduction: A previously healthy and a fully vaccinated 5-year-old pre-schooler-aged male who presented to the ER with an insidious onset of decreasing level of consciousness and headaches before developing Status Epilepticus, and requiring admission to the PICU; with a final [....] » Read More

Speaker at Infectious Diseases Conferences - Sinisa Skocibusic
Oral Presentation (In-Person)
Sinisa Skocibusic, Center for Prevention and Outpatient Treatment of Addiction Mostar, Bosnia and Herzegowina

Background: The healthcare system in Bosnia and Herzegovina continues to face a significant burden due to the presence of chronic hepatitis C. Individuals who engage in the use of injectable drugs represent a substantial reservoir of the hepatitis C virus, hence presenting an end [....] » Read More

Speaker at Infection Conferences - Anil Budania
Oral Presentation (In-Person)
Anil Budania, All India Institute of Medical Sciences, India

Introduction: Urethritis and cervicitis, in the majority of cases, are caused by sexually transmitted agents. They presents as discharge, pain, burning sensation but sometimes the patient may remain asymptomatic. Neisseria gonorrhoeae (Gono-coccal) and chlamydia trachomatis (Non- [....] » Read More

Speaker at Infection Conferences - Hamza Rashid
Oral Presentation (Virtual)
Hamza Rashid, Peterborough City Hospital, United Kingdom

Leptospirosis is a zoonotic bacterial infection primarily caused by Leptospira species. This disease, characterized by a wide range of symptoms, is uncommon in the UK, with an incidence of 0.14 cases per 100,000. This oral presentation is the case of a 56-year-old male fish farme [....] » Read More

Speaker at Infection Conferences - Katarzyna Grudlewska-Buda
Oral Presentation (Virtual)
Katarzyna Grudlewska-Buda, Nicolaus Copernicus University in Torun, Poland

Bacteria of the Enterococcus genus are opportunistic microorganisms widely prevalent in the environment. An important source of pathogenic strains of Enterococcus spp. are farm animals and their living environment. Enterococcus faecium and Enterococcus faecalis species are most o [....] » Read More

Speaker at Infectious Diseases Conference - Anastasiia Panova
Oral Presentation (Virtual)
Anastasiia Panova, Bauman Moscow State Technical University, Russian Federation

COVID-19 type virus infection in a group of individuals results from the uptake by the lungs of these individuals of virions from the local atmosphere created by infected members of the group. The concentration of virions is determined by the social activity of group members and [....] » Read More

Speaker at Infectious Diseases Conference - Ahmed Abdalla
Oral Presentation (Virtual)
Ahmed Abdalla, Wexford General Hospital, Ireland

Adenovirus is a frequent cause of mild respiratory tract infection and gastroenteritis in children, it can cause severe respiratory illness in immunocompromised patients. Outbreaks and aggressive respiratory symptoms have been reported in military camps. Epidemics are well known [....] » Read More

Speaker at Infectious Diseases Conferences - Pedro Plans Rubio
Oral Presentation (Virtual)
Pedro Plans Rubio, Public Health Agency of Catalonia, Spain

The emergence of novel SARS-CoV-2 variants has raised concerns about the ability of COVID-19 vaccination programs to establish adequate herd immunity levels in the population. Adapted mRNA COVID-19 vaccines against BA.1 and BA.4-5 Omicron variants can provide a greater immunity a [....] » Read More

Speaker at Infectious Diseases Conferences - Pedro Plans Rubio
Oral Presentation (Virtual)
Pedro Plans Rubio, Public Health Agency of Catalonia, Spain

The aim of this study was to identify factors associated with non-adherence to tuberculosis (TB) preventive treatment among contacts with latent TB infection for new cases of pulmonary TB cases reported in Catalonia in 2019–2021. All contacts aged 18 years or older with a l [....] » Read More

Speaker at Infection Conferences - Weixi Shen
Oral Presentation (Virtual)
Weixi Shen, Shenzhen Tianyou Medical Institute, China

The recent global outbreaks of infectious diseases such as SARS and COVID-19 have inflicted damage on both individuals and societies worldwide. To develop scientific strategies for prevention and precise treatment measures to counteract such outbreaks is imperative. After 28 year [....] » Read More

Speaker at Infectious Diseases Conferences - Huiyi Feng
Oral Presentation (Virtual)
Huiyi Feng, Shenzhen Hospital of Southern Medical University, China

In recent years, there have been frequent outbreaks of infectious diseases such as SARS and COVID-19, which pose a significant threat to human life, health, and socio-economic development. Despite the lack of a specific medicine to combat virus infections, the medical community a [....] » Read More

Speaker at Infectious Diseases Conferences - Shweta Chelluboina
Oral Presentation (Virtual)
Shweta Chelluboina, Bharati Vidyapeeth (Deemed to be University), India

Dengue is a mosquito-borne viral disease endemic in many countries particularly in the tropical and sub-tropical regions of the world. It is caused by one of the four serotypes of dengue virus (DENV). As the four serotypes are co-circulating, multiple encounters with heterologous [....] » Read More

Speaker at Infection Conference - Himani Agri
Oral Presentation (Virtual)
Himani Agri, Indian Veterinary Research Institute, India

The uroculturome indicates the profile of culturable microbes inhabiting urinary tract infections (UTIs). UTIs are often caused by opportunistic pathogens and it is necessary to do urine culture to find an effective antimicrobial to treat UTIs. This study targeted to understand t [....] » Read More

Speaker at Infection Conferences - Mohammad Alshomrani
Oral Presentation (Virtual)
Mohammad Alshomrani, Riyadh Regional Laboratory and Blood Bank, Saudi Arabia

Although S. aureus UTI is known to be associated with other risk factors such as urinary catheterization, long hospital stay, or complicated UTI, our results show the community-acquired presentation of UTI. Trimethoprim-sulfamethoxazole may be used as an effective treatment for U [....] » Read More

Speaker at Infectious Diseases Conference - Nawal AlKaabi
Oral Presentation (Virtual)
Nawal AlKaabi, Sheikh Khalifa Medical City, Abu Dhabi Health Services Company (SEHA), United Arab Emirates

Background: In response to the COVID-19 pandemic, innovative treatments and preventive measures continue to be pivotal. This interim analysis examines the use of AZD7442, a long-acting antibody (LAAB), as a pre-exposure prophylactic (PrEP) agent against the SARS-CoV-2 virus, aimi [....] » Read More

Speaker at Infection Conference - Ahmad Subhi
Oral Presentation (Virtual)
Ahmad Subhi, Al Qassimi Hospital, United Arab Emirates

In 2016, according to the United States Centers for Disease Control and Prevention (CDC), and Public Health England, Candida auris, has been labeled as an emerging multidrug-resistant (MDR) yeast. Despite causing significant mortality, there are still no available Minimum inhibit [....] » Read More

Speaker at Infectious Diseases Conference - Helmi Ernandes
Oral Presentation (Virtual)
Helmi Ernandes, Mohamed Kassab Institute of Orthopedics, Tunisia

Background: Periprosthetic joint infection (PJI) is the most common and feared arthroplasty complication. Ralstonia pickettii is an opportunistic Gram-negative bacterium, causing nosocomial infections in immunocompromised patients. It is an environmental bacterium that has been a [....] » Read More

Speaker at Infectious Diseases Conference - Helmi Ernandes
Oral Presentation (Virtual)
Helmi Ernandes, Mohamed Kassab Institute of Orthopedics, Tunisia

Background: The rate of septic arthritis after arthroscopy ranges from 0.15% to 1%. Staphylococci are the leading causative organisms after knee arthroscopy whereas Cutibacterium acnes is often the causative organism after shoulder arthroscopy. Gram-negative bacillary infections [....] » Read More

Speaker at Infectious Diseases Conferences - Nicole Abdullah
Oral Presentation (Virtual)
Nicole Abdullah, Faculdades Pequeno Príncipe, Brazil

Introduction: Severe acute respiratory syndrome coronavirus-2 virus (SARS-COV-2) was officially identified on January 2020 following investigations of pneumonia cases of unknown origin. Clinical presentation presents variations in symptom duration, severity, and complications. Am [....] » Read More

Speaker at Infection Conferences - Aung Sitt Naing
Oral Presentation (Virtual)
Aung Sitt Naing, Eastern Virginia Medical School, United States

Introduction: Schistosomiasis is a parasitic infection endemic to Asia, Africa, and South America, and can be an unusual cause of pelvic pain in women. Due to similar symptoms with endometriosis, the diagnosis is often missed in regions of the world where Schistosomiasis is uncom [....] » Read More

Speaker at Infection Conferences - Aung Sitt Naing
Oral Presentation (Virtual)
Aung Sitt Naing, Eastern Virginia Medical School, United States

Introduction: Mycobacterium shimoidei is a rare, slow-growing nontuberculous mycobacterium, first isolated in Japan in 1968. Only one case was reported in the United States, out of a total of fifteen cases reported worldwide. Due to its rarity and the current understanding o [....] » Read More

Speaker at Infectious Diseases Conferences - Parvin Dehghan
Oral Presentation (Virtual)
Parvin Dehghan, Isfahan University of Medical Sciences, Iran (Islamic Republic of)

Background: Excessive and inappropriate use of antibiotics can lead to increased antibiotic-resistant strains of microorganisms. Actinomycetes, a versatile microbial group, are well known for producing important metabolites such as antibiotics, enzymes, herbicides, and anticancer [....] » Read More

Speaker at Infectious Diseases Conferences - Parvin Dehghan
Oral Presentation (Virtual)
Parvin Dehghan, Isfahan University of Medical Sciences, Iran (Islamic Republic of)

Introduction: timely identification and treatment of trichosporonosis is important due to the severity of pathogenesis and different treatment from candidiasis and as a result of its high mortality. In this study, in addition to determining the abundance of this fungus in clinica [....] » Read More

Speaker at Infectious Diseases Conferences - Fiona Murphy
Poster Presentation (In-Person)
Fiona Murphy, Mayo Clinic, United States

A 59-year-old male with a history of relapsed refractory Chronic Lymphocytic Leukemia and associated hypogammaglobulinemia presented to our medical service with neutropenic fever, a skin lesion, and progressive pulmonary infiltrates. He had been evaluated for cough and neutrop [....] » Read More

Speaker at Infectious Diseases Conferences - David Stiles
Poster Presentation (In-Person)
David Stiles, Recursion Pharmaceuticals, United States

REC-3964 is an oral, novel, diazepinedione-class chemical entity identified from Recursion’s high-content phenotypic imaging platform. REC-3964 inhibits toxins associated with Clostridioides difficile infection (CDI). In a disease-relevant hamster model of acute CDI, REC [....] » Read More

Speaker at Infectious Diseases Conferences - Maria Aguilar Amaya
Poster Presentation (In-Person)
Maria Aguilar Amaya, Arizona State University, United States

During this poster presentation, the presenter will discuss the development of the academic detailing (AD) DISH-AZ (Detailing for Improved Sexual Health in Arizona) program and will explain the methodological triangulation approach that is being used in Arizona. By employing a me [....] » Read More

Speaker at Infectious Diseases Conferences - Sneha Thatipelli
Poster Presentation (In-Person)
Sneha Thatipelli, University of Pennsylvania, United States

Background: Human Immunodeficiency Virus (HIV) continues to be a major public health problem in the United States. Pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV, but uptake remains low, especially among women. Furthermore, HIV prevention in pregnant indivi [....] » Read More

Speaker at Infectious Diseases Conference - Lauren Panny
Poster Presentation (In-Person)
Lauren Panny, US Army Medical Research Institute of Infectious Diseases, United States

Alphaviruses, such as eastern equine encephalitis virus (EEEV), are genetically encoded by a single positive sense RNA genome. Following glycoprotein-assisted entry into the cells, fusion with the endosomal membrane, and capsid release, translation of the non-structural proteins [....] » Read More

Speaker at Infectious Diseases Conference - Elucir Gir
Poster Presentation (In-Person)
Elucir Gir, University of Sao Paulo, Ribeirao Preto College of Nursing, Brazil

Introduction: Facing the COVID-19 pandemic caused damage to the physical health of nurses, especially those who worked on the so-called front line, as they were exposed to constant risks of contamination, exhaustive workload and difficulties in the availability of inputs, such as [....] » Read More

Speaker at Infectious Diseases Conference - Elucir Gir
Poster Presentation (In-Person)
Elucir Gir, University of Sao Paulo, Ribeirao Preto College of Nursing, Brazil

Introduction: Long COVID comprises a complex, multidimensional, progressive and impactful syndrome characterized by the persistence of residual symptoms after the initial COVID-19 infection, without an alternative diagnosis or associated condition. Objective: To identify the p [....] » Read More

Speaker at Infectious Diseases Conferences - Preslava Hristova
Poster Presentation (In-Person)
Preslava Hristova, Medical University - Pleven, Bulgaria

Background: Atlantibacter hermannii, previously known as Escherichia hermannii is a rare causative agent of human infections. Several reports testify that the most frequently infected patients are immunosuppressed, especially those undergoing hemodialysis. Materials and Method [....] » Read More

Speaker at Infectious Diseases Conferences - Reem Alblooshi
Poster Presentation (In-Person)
Reem Alblooshi, Cleveland Clinic Abu Dhabi, United Arab Emirates

We describe a case of a 24-year-old male who presented with fever associated with flu-like symptoms that progressed to skin involvement with a diffuse erythematous and painful rash necessitating inpatient admission for further management. His physical examination was notable for [....] » Read More

Speaker at Infectious Diseases Conference - Simona Yoffe Deri
Poster Presentation (In-Person)
Simona Yoffe Deri, Sheba Hospital, Israel

Influenza B-associated rhabdomyolysis is relatively rare. Herein, we describe a retrospective case-series of five children hospitalized in a single institution for rhabdomyolysis from PCR-confirmed Influenza B. Viral sequencing revealed a novel deletion of one amino acid in the v [....] » Read More

Speaker at Infectious Diseases Conference - Simona Yoffe Deri
Poster Presentation (In-Person)
Simona Yoffe Deri, Sheba Hospital, Israel

Background: Necrotizing Enterocolitis (NEC), one of the most severe emergencies in neonates, is a multifactorial disease with diverse risk factors. Objectives: To compare between the clinical and laboratory characteristics of premature infants diagnosed with early-onset NEC (E [....] » Read More

Speaker at Infection Conferences - Lilishia Gounder
Poster Presentation (In-Person)
Lilishia Gounder, University of KwaZulu-Natal, South Africa

Background: HIV drug resistance (HIVDR) remains a major threat to achieving sustainable viral suppression in patients on antiretroviral therapy (ART). In South Africa, since its rollout in December 2019, dolutegravir (DTG) has been the preferred ART backbone. Methods: We curat [....] » Read More

Speaker at Infectious Diseases Conferences - Yen Chin Liu
Poster Presentation (In-Person)
Yen Chin Liu, Chang Gung University, Taiwan

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can dysregulate host antiviral responses, including interferon production, to facilitate viral replication and spread via interacting with their hosts; however, the impact of the SARS-CoV-2 Omicron nucleocapsid protein [....] » Read More

Speaker at Infectious Diseases Conferences - David Geiner Mejia Zavala
Poster Presentation (In-Person)
David Geiner Mejia Zavala, Universidad Peruana Cayetano Heredia, Peru

The Cystic Echinococcosis in Peru, is an important problem in public health and in the economy, causing great economic losses both in livestock production and in the recovery of the health of the affected human population (Náquira C., 2010). Human Cystic Echinococcosis has [....] » Read More

Speaker at Infection Conference - Andrew Kimera
Poster Presentation (In-Person)
Andrew Kimera, Makerere University, Uganda

Background: Hepatitis B virus (HBV) is associated with several acute and long-term complications and vaccination is the cornerstone of prevention.  A recent outbreak in Gulu, Uganda, one of the districts covered by a mass vaccination campaign, suggests low uptake of HBV vacc [....] » Read More

Speaker at Infection Conference - Andrew Kimera
Poster Presentation (In-Person)
Andrew Kimera, Makerere University, Uganda

Background: Hepatitis B virus vaccination plays a crucial role in preventing Hepatitis B infection, particularly in high-risk groups such as children under-five, who have a 60-90% higher chance of seroconversion. As per the World Health Organization (WHO), about 5–10% of in [....] » Read More

Speaker at Infectious Diseases Conference - Pere Domingo Pedrol
Poster Presentation (In-Person)
Pere Domingo Pedrol, Hospital de la Santa Creu i Sant Pau, Spain

Background: Triple- or quadruple drug regimens (3 or 4DR) remain the gold standard for HIV treatment. However, there is currently a trend towards a reduction in the number of drugs from 3 or 4DR to double-drug regimens (2DR) based on Integrase Strand Transfer Inhibitors (INSTIs). [....] » Read More

Speaker at Infectious Diseases Conferences - Maria De Fatima Ferreira Da Cruz
Poster Presentation (In-Person)
Maria De Fatima Ferreira Da Cruz, Fundacao Oswaldo Cruz, Brazil

Malaria is a public health problem and the cases diagnosed in the capital of Roraima have the potential to characterize the burden of the disease in the state. This study aimed to describe the epidemiological, clinical and laboratory aspects of malaria cases diagnosed in Boa Vist [....] » Read More

Speaker at Infectious Diseases Conference - Edeline Anne Dondonilla
Poster Presentation (Virtual)
Edeline Anne Dondonilla, Ospital ng Makati, Philippines

Background: The Philippines ranks fourth worldwide in tuberculosis incidence and is considered as a high-burden country of tuberculosis in the world. Differences in the pathophysiology and clinical presentation of TB in children make diagnosis more challenging than in adults.&nbs [....] » Read More

Speaker at Infection Conferences - Andreas Christodoulou
Poster Presentation (Virtual)
Andreas Christodoulou, Serres General Hospital, Greece

This case report describes a 57-year-old man with a history of coronary artery bypass grafting (CABG) and mitral valve replacement who presented with fever, rigors, and focal neurological symptoms. The patient was diagnosed with late-onset prosthetic valve endocarditis (PVE) comp [....] » Read More

Speaker at Infection Conference - Veronika Nemethova
Poster Presentation (Virtual)
Veronika Nemethova, Selecta Biotech SE, Slovakia (Slovak Republic)

Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019, the number of confirmed cases worldwide exceeded 770 million in 222 countries by March 2024, with more than 7 million confirmed deaths, according to the statistics from the World Health O [....] » Read More

Speaker at Infectious Diseases Conferences - Comfort Oluladun Aiki Raji
Poster Presentation (Virtual)
Comfort Oluladun Aiki Raji, University of Ibadan, Nigeria

Protoparvoviruses are a diverse genus of small, non-enveloped, single stranded DNA viruses in the Parvovirinae subfamily of the virus family Parvoviridae. Three of the fifteen member species of this genus have been associated with human infections, while some others infect domest [....] » Read More

Speaker at Infectious Diseases Conference - Elinam Adzo Agbobli
Poster Presentation (Virtual)
Elinam Adzo Agbobli, Noguchi Memorial Institute for Medical Research, Ghana

Ticks play a significant role in disease transmission, rivaling mosquitoes in importance, yet knowledge gaps persist regarding ticks of public health importance. Their remarkable diversity stems from complex life cycles and interactions with hosts, leading to their ubiquity acros [....] » Read More

Speaker at Infection Conferences - Filip Razga
Poster Presentation (Virtual)
Filip Razga, Selecta Biotech SE, Slovakia (Slovak Republic)

More than four years after the outbreak of the COVID-19 pandemic, the SARS-CoV-2 virus is still causing lasting damage around the world, impacting the health and lives of many. Preventive measures, such as widespread administration of vaccines, is playing a role in reducing the s [....] » Read More

Speaker at Infectious Diseases Conference - Ahsan Ehtesham
Poster Presentation (Virtual)
Ahsan Ehtesham, Hamad Medical Corporation, Qatar

Background: Cardiac aspergillosis is a rare form of Invasive Aspergillus infection that carries high mortality despite aggressive treatment. It usually occurs in patients with underlying cardiac abnormalities such as cardiac lesions, prosthetic valves, cardiac devices, and heart [....] » Read More

Speaker at Infection Conferences - Ihtisham Ul Haq
Poster Presentation (Virtual)
Ihtisham Ul Haq, Federal University of Minas Gerais, Brazil

Uropathogenic Escherichia coli (UPECs) is the leading pathogen involved in urinary tract infection. Although quinolones are widely used in these cases, the resistance of UPECs to this class has been growing significantly, challenging the effectiveness of antibacterial therapy. Th [....] » Read More

Speaker at Infectious Diseases Conference - Franciela Golden
Poster Presentation (Virtual)
Franciela Golden, Mayo Clinic Jacksonville, United States

Streptococcus Gordonii (SG) is an alpha hemolytic gram-positive streptococcus bacterium most commonly present in the oral cavity and gastrointestinal tract [1]. Despite an increase in the incidence of Infective Endocarditis, SG cases reported on a native aortic valve are relative [....] » Read More

Speaker at Infectious Diseases Conference - Nikki Kasal
Poster Presentation (Virtual)
Nikki Kasal, University of Chicago Pritzker School of Medicine, United States

Background: Awareness and uptake of HIV pre-exposure prophylaxis (PrEP) remains low among Black/African American cisgender women at risk for HIV acquisition. Primary care appointments present a valuable opportunity for introducing PrEP to clients; however, primary care providers [....] » Read More

Speaker at Infectious Diseases Conferences - Ashin Mehta
Poster Presentation (Virtual)
Ashin Mehta, Medical College of Wisconsin, United States

A 56-year-old male with end-stage renal disease undergoing home peritoneal dialysis presented with abdominal pain, nausea, and altered mental status. White blood cell count was 12.3 10e3/uL, urinalysis was positive for 2+ blood, and peritoneal fluid contained a total nucleated ce [....] » Read More

Speaker at Infection Conferences - Melanie Rosado
Poster Presentation (Virtual)
Melanie Rosado, University of Utah, United States

A 4-day-old term infant with a low EOS risk score originally presented to the ED with six hours of lethargy and poor feeding. Initial work-up was demonstrated acute liver failure (PT/INR 18.5, ALT>90, AST>300), hypoglycemia, hyperferritinemia (ferritin >44,000), severe t [....] » Read More

Speaker at Infectious Diseases Conference - Aaron Briggs
Poster Presentation (Virtual)
Aaron Briggs, University of California San Diego, United States

Background: The World Health Organization (WHO) estimated the global incidence of syphilis among adults to be approximately 7.1 million in 2020. The following year, the American Centers for Disease Control and Prevention (CDC) reported a 32% increase in the incidence of primary/s [....] » Read More

Speaker at Infectious Diseases Conferences - Kathleen Maguire
Poster Presentation (Virtual)
Kathleen Maguire, University of California, United States

We present a case of peritoneal coccidioidomycosis in an immunocompetent female patient initially diagnosed with tuberculosis at an outside hospital who presented with suspected RIPE therapy failure. She presented with a history of recurrent ascites, headaches, and shortness of b [....] » Read More

Speaker at Infectious Diseases Conferences - Jusup Andi Purwanto
Poster Presentation (Virtual)
Jusup Andi Purwanto, Bala Keselamatan Bokor Hospital, Indonesia

Background: Fever is the most commonly encountered issue in hospitalized patients. The most frequently used antipyretics to address fever are paracetamol and metamizole. The choice of drug administration route is considered to potentially reduce the treatment period, and also aff [....] » Read More

Speaker at Infection Conferences - Yuanbin Wang
Poster Presentation (Virtual)
Yuanbin Wang, Population Health Impact Inst, United States

Introduction: This study focuses on the relationship between COVID-19 infection and myocarditis across different age groups. Previous studies have indicated that both natural Covid-19 infection and MRNACovid vaccination might trigger subsequent myocarditis especially in younger a [....] » Read More

Speaker at Infectious Diseases Conferences - Filipa de Aragao
Poster Presentation (Virtual)
Filipa de Aragao, Incremental Action Consulting Lda, Portugal

Background and Goal: When bloodstream infection (BSI) is suspected, empirical broad-spectrum antimicrobial treatment (AMT) is immediately initiated after sampling for blood cultures. In the context of an increasing rate of multidrug-resistant organisms, rapid microbiological inve [....] » Read More

Speaker at Infection Conferences - Silvia Giono Cerezo
Keynote Presentation (In-Person)
Silvia Giono Cerezo, Instituto Politecnico Nacional, Mexico

Bloodstream infections due to Gram-negative bacilli is a highly consequential nosocomial infection with serious consequences and even more so because the organisms are usually highly resistant to antimicrobials. The aims of this study were to describe incidence of bacteremia caus [....] » Read More

Speaker at Infection Conferences - Seki Masafumi
Keynote Presentation (Virtual)
Seki Masafumi, Saitama Medical University International Medical Center, Japan

Background: The mortality of SARS-CoV-2 infection in non-vaccinated patients is still thought to be high despite the appearance of the omicron subvariant. A total of 36 adult, non-vaccinated patients who were hospitalized with SARS-CoV-2 infection during the omicron variant surge [....] » Read More

Speaker at Infection Conferences - Stephen Hsu
Keynote Presentation (Virtual)
Stephen Hsu, Augusta University, United States

Background: Severe Acute Respiratory Syndrome (SARS) coronavirus 2 (SARS-CoV-2) is responsible for the 2019 coronavirus epidemic (COVID-19). SARS-CoV-2 infection is associated with high mortality and morbidity worldwide. A common sequela is chronic neurologic diseases, which seve [....] » Read More

Speaker at Infection Conferences - Reza Nassiri
Keynote Presentation (Virtual)
Reza Nassiri, Michigan State University, United States

Antibiotic resistance (AR) is both clinical and global public health concerns. In numerous countries, physicians have very few other options available to treat MDR and XDR infections. The World Health Organization (WHO) acknowledges AR is one of the top global public he [....] » Read More

Speaker at Infectious Diseases Conferences - Ranjan Ramasamy
Keynote Presentation (Virtual)
Ranjan Ramasamy, IDFISH Technology, United States

While many advances in biological sciences have been applied in medicine, agriculture and industry with great benefit, some recent trends in society, governance structures and communications, appear to be hampering the use of new scientific findings for controlling infectious dis [....] » Read More

Speaker at Infectious Diseases Conference - Camila Melo de Freitas
Oral Presentation (In-Person)
Camila Melo de Freitas, Faculdade Pitagoras de Medicina de Eunapolis, Brazil

Pasteurella multocida is a gram-negative bacterium commonly found in the respiratory and gastrointestinal tracts of animals, such as cats, dogs and birds. This bacterium is known to cause a variety of infections in animals and can occasionally be transmitted to humans, resulting [....] » Read More

Speaker at Infectious Diseases Conferences - Luis Felipe Vargas Garcia
Oral Presentation (In-Person)
Luis Felipe Vargas Garcia, Hospital Christus Muguerza Alta Especialidad, Mexico

Lyme disease (Lyme borreliosis) is a multisystem zoonotic disease caused by the spirochete Borrelia burgdorferi. Individuals without treatment may progress to a disseminated stage having cardiac, neurological or another systemic manifestations. We present a rare case of a 40-year [....] » Read More

Speaker at Infection Conference - Alexis Torres Rodriguez
Oral Presentation (In-Person)
Alexis Torres Rodriguez, Universidad Central del Caribe Internal Medicine Residency, Puerto Rico

Introduction: Pyogenic ventriculitis is characterized by ependymal lining inflammation of the cerebral ventricular system and presence of suppurative fluid in the ventricles. Risk factors include a compromised immunity such as human immunodeficiency virus, diabetes, and cancer. T [....] » Read More

Speaker at Infectious Diseases Conferences - Angelica Ludena
Oral Presentation (In-Person)
Angelica Ludena, Universidad Central del Caribe, Puerto Rico

Leptospirosis is a zoonotic disease produced by spirochetes of Leptospira, with an incidence ten times higher in tropical regions like Puerto Rico, in comparison to the rest of the world. The principal reservoir are rats, dogs, cats and farm animals with excreted infected urine, [....] » Read More

Speaker at Infection Conference - Vineeta Arora
Oral Presentation (In-Person)
Vineeta Arora, AIIMS-New Delhi, India

Background: Trauma represents a significant public health issue in India, with substantial morbidity and mortality. Rapid access to appropriate care is essential for favorable post-injury outcomes. However, resource allocation strategies ensuring equitable access in developing na [....] » Read More

Speaker at Infectious Diseases Conference - Camila Melo de Freitas
Oral Presentation (In-Person)
Camila Melo de Freitas, Faculdade Pitagoras de Medicina de Eunapolis, Brazil

Monkeypox (Mpox) is an emerging viral zoonosis that has gained increasing attention due to its clinical similarity to smallpox and its ability to cause sporadic outbreaks in human communities. This condition, caused by the Monkeypox virus (MPXV), belonging to the Poxviridae famil [....] » Read More

Speaker at Infection Conferences - Dong Hyun Kim
Oral Presentation (In-Person)
Dong Hyun Kim, Hallym University College of Medicine, Korea, Republic of

The primary objective of this investigation is to estimate the population prevalence of SARS-CoV-2 antibodies, monitor the waning pattern of seroprevalence, and develop forthcoming vaccination strategies through a longitudinal study using a population-representative sample over t [....] » Read More

Speaker at Infectious Diseases Conference - Anupma Harshal W
Oral Presentation (In-Person)
Anupma Harshal W, Consultant-Kotak Education Foundation & Ashoka University, India

Background: Antimicrobial resistance (AMR) is a global public health concern that threatens the effectiveness of antibiotics and other antimicrobial drugs. As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective and infections become diffi [....] » Read More

Speaker at Infectious Diseases Conference - Jonathan Lambo
Oral Presentation (In-Person)
Jonathan Lambo, Avalon University School of Medicine, United States

Background: Globally, over 13 billion COVID-19 vaccine doses have been administered, which increases the risk of vaccine-related safety concerns. BNT162b2 and mRNA-1273 COVID-19 vaccines have been used for mass vaccinations in Curaçao, but information on adverse events (AE [....] » Read More

Speaker at Infectious Diseases Conference - Abdallah Musa Abdallah
Oral Presentation (In-Person)
Abdallah Musa Abdallah, Qatar University, Qatar

Background: Coronavirus disease (COVID-19) is an infectious disease with a heterogeneous clinical presentation caused by the novel coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The distinctive features of COVID-19 infection encompass a clinical sp [....] » Read More

Speaker at Infection Conference - Patrone Rebecca Risenga
Oral Presentation (In-Person)
Patrone Rebecca Risenga, University of South Africa, South Africa

Human Immunodeficiency Virus creates disruption in the lives of individuals, families, organisations, and communities at large. The introduction of the antiretroviral treatment brought hope but also brought challenges, especially around the issue of adherence which is important f [....] » Read More

Speaker at Infectious Diseases Conferences - Francisco Borges Costa
Oral Presentation (In-Person)
Francisco Borges Costa, State University of Maranhão, Brazil

Rabies is an acute viral disease that affects mammals, caused by an RNA virus belonging to the family Rhabdoviridae and the genus Lyssavirus. The disease is transmitted through bites or scratches from an infected animal. Rabies was one of the first infectious diseases to be scien [....] » Read More

Speaker at Infection Conference - Muhammad Amjad Khan
Oral Presentation (In-Person)
Muhammad Amjad Khan, National Institutes of Health, Pakistan

Over the past few decades fungal infections have emerged as a constantly on the rise global health challenge, resulting in approximately 1.7 million deaths every year. Moreover, the long-term therapeutic application and prophylactic use of antifungal drugs in high-risk patients h [....] » Read More

Speaker at Infectious Diseases Conferences - Francisco Borges Costa
Oral Presentation (In-Person)
Francisco Borges Costa, State University of Maranhão, Brazil

Rabies is an acute viral disease with extremely high lethality, still causing approximately 59,000 human deaths worldwide every year. Despite being a disease studied for many years and having a very efficient prophylaxis, a high incidence rate is observed in developing countries. [....] » Read More

Speaker at Infection Conferences - Demboux Lyelet Jordy Exauce
Oral Presentation (In-Person)
Demboux Lyelet Jordy Exauce, National Public Health Laboratory, Congo

Context: Respiratory tract infections (RTIs) are one of the most common infectious diseases in children and represent a major cause of morbidity, hospital admission and mortality worldwide, with an estimated 3-5 million deaths per year. Although children are most at risk, adults [....] » Read More

Speaker at Infectious Diseases Conference - Niranjan Nayak
Oral Presentation (In-Person)
Niranjan Nayak, Manipal College of Medical Sciences, Nepal

Background: Urinary Tract Infection (UTI) due to Salmonella Typhi is uncommon, though there are scanty reports of bacteriuria caused by nontyphoidal Salmonellae and other gram negative bacilli. However, cases of bacteriuria with UTI due to nontyphoidal Salmonellae were more [....] » Read More

Speaker at Infectious Diseases Conferences - Rosshini Kummararaj
Oral Presentation (In-Person)
Rosshini Kummararaj, Yenepoya Medical College, India

Introduction: A parasite may look docile and harmless but it can create havoc in human eyes. Early detection and timely treatment can prevent blindness. We report three cases of parasites in the eye with varying presentations. Case 1: A 76-year-old gentleman, a pet lover and a [....] » Read More

Speaker at Infection Conference - Anju Kaushal
Oral Presentation (Virtual)
Anju Kaushal, New Zealand Organization for Quality, New Zealand

The activation of double stranded interference RNA occurring in the host cell is a natural phenomenon to control the over transcriptional effects of genes that could suppress the translational patterns. This genetic ability is currently being exploited in making the medicines to [....] » Read More

Speaker at Infection Conference - Keekok Lee
Oral Presentation (Virtual)
Keekok Lee , University of Manchester, United Kingdom

This contribution is an attempt to clarify some of the issues raised by the COVID-19 pandemic when it hit the globe roughly between 2020 and 2022 from the perspective of geopolitics. It is, therefore, per se, not a discussion from the narrow medical point of view but the politica [....] » Read More

Speaker at Infection Conferences - Karen Ivy Bacsain
Oral Presentation (Virtual)
Karen Ivy Bacsain, Universidad de Santa Isabel Health Services, Philippines

Background: The Philippines, being a tropical country, makes for an interesting reservoir for diverse bacterial flora. One such pathogen is the Burkholderia pseudomallei, a Gram-negative pathogen, found in moist soil and rainwater. Cases increase during the monsoon rains, which o [....] » Read More

Speaker at Infectious Diseases Conferences - Ro Janna Jamahari Jamiri Sarapuddin
Oral Presentation (Virtual)
Ro Janna Jamahari Jamiri Sarapuddin, Ospital ng Maynila Medical Center, Philippines

Background: While there is evidence that the burden of COVID-19 infection in hospitalized children is lesser than in their adult counterparts, currently, there are limited reports describing clinical data on COVID-19 patients particularly in pediatric population. Objective: To [....] » Read More

Speaker at Infection Conference - Xiaohua Li
Oral Presentation (Virtual)
Xiaohua Li, Henan Provincial People's Hospital, China

Fungal keratitis is one of the leading causes of blindness of infected corneal diseases, but the pathogenesis of fungal keratitis is not fully understood and therefore the treatment of the disease by medication is still under investigation. In the current study, we sought to stud [....] » Read More

Speaker at Infectious Diseases Conference - Tran Lam Tu Quyen
Oral Presentation (Virtual)
Tran Lam Tu Quyen, China Medical University, Taiwan

The Acinetobacter baumannii group (AB-group), encompassing A. baumannii, A. pittii, A. nosocomialis, along with recent additions A. seifertii and A. dijkshoorniae, have emerged as prominent nosocomial pathogens with a global presence. Infections with antibiotic-resistant Acinetob [....] » Read More

Speaker at Infection Conference - Aji Antony
Oral Presentation (Virtual)
Aji Antony, Government Medical College Kozhikode, India

Background: Histoplasmosis is an endemic mycosis that is usually asymptoma c but occasionally results in severe illness. While it is endemic in some regions of the world, including America, Africa, and parts of Asia, it is considered rare in India. Most pa ents who develop dissem [....] » Read More

Speaker at Infection Conference - Aji Antony
Oral Presentation (Virtual)
Aji Antony, Government Medical College Kozhikode, India

Introduction: Stroke in a case of HIV, occurs by various mechanisms. The mechanisms include vasculi s secondary to opportunis c infec ons, HIV associated vasculopathy, cardioembolic stroke and HIV associated coagulopathy. Of these, the HIV associated vasculopathy is a diagnosis o [....] » Read More

Speaker at Infectious Diseases Conferences - Saliha Gokce Alagoz
Oral Presentation (Virtual)
Saliha Gokce Alagoz, Gaziantep University, Turkey

Objective: Ebstein-Barr virus asymptomatically infects about 95% of adults worldwide. It is the main cause of infectious mononucleosis, which is observed most frequently in adolescents. Because EBV is an opportunistic virus, it is more difficult to diagnose. It is not the first f [....] » Read More

Speaker at Infection Conferences - Tania Ayllon Santiago
Oral Presentation (Virtual)
Tania Ayllon Santiago, Alfonso X El Sabio University, Spain

West Nile virus (WNV), classified under the Orthoflavivirus genus and Flaviviridae family, is a reemerging flavivirus perpetuated in an enzootic cycle between avian hosts and mosquito vectors. Periodic outbreaks of WNV in humans and horses can result in neuroinvasive disease and [....] » Read More

Speaker at Infectious Diseases Conference - Nashwa Elsayed Elkasaby
Oral Presentation (Virtual)
Nashwa Elsayed Elkasaby, Medical Microbiology and immunology Department, Faculty of medicine, Mansoura University, Egypt

Background and aim: Human parechovirus (HPeV) has emerged as a pathogen associated with acute gastroenteri? tis (AGE). Aim: To detect the presence of HPeV in the stool samples from Egyptian children with AGE seeking care and the pos? sibility of its co?infection with other ent [....] » Read More

Speaker at Infectious Diseases Conference - Aparna M Menon
Oral Presentation (Virtual)
Aparna M Menon, Government Medical College Kozhikode, India

Introduction: Tuberculosis is chronic infection caused by mycobacterium tuberculosis and primarily attacks the lung. Tuberculosis of thyroid gland is an uncommon entity as the gland is resistant to infection due to bactericidal property of colloid high iodine content and extensiv [....] » Read More

Speaker at Infection Conference - Dian Wulandaru Sukmaning Pertiwi
Oral Presentation (Virtual)
Dian Wulandaru Sukmaning Pertiwi, University of Indonesia, Indonesia

Objective: Survival rate and quality of life of children with chronic hepatobiliary disease has improved since the development of liver transplantation. Incidence of bacterial infection is 36– 79% at 6 months post-transplantation and mortality of 3.0–10.6% at 3 months [....] » Read More

Speaker at Infectious Diseases Conferences - Amitabha Majumdar
Oral Presentation (Virtual)
Amitabha Majumdar, Unilever R&D, United Kingdom

Background: As the world returns to pre-pandemic behavior patterns, surges in infections caused by antibiotic-resistant bacterial strains and seasonal viruses are a cause of serious concern. Persistent circulating infections exert socio-economic burdens on public health systems a [....] » Read More

Speaker at Infection Conferences - Komal Mushtaq
Oral Presentation (Virtual)
Komal Mushtaq, DHQ Sheikhupura, Pakistan

Introduction: Measles virus is an aerosol borne and one of the most Contagious Pathogens1. Almost every measles virus Infection becomes Clinically manifest, furthermore, it can cause fatal complications and has high morbidity and mortality. Measles virus infection is a vaccine pr [....] » Read More

Speaker at Infectious Diseases Conferences - Lauren Middlebrooks
Oral Presentation (Virtual)
Lauren Middlebrooks, Emory University, United States

The Centers for Disease Control and Prevention recommends HIV screening for all patients ≥13 years. Parts of Metro Atlanta have HIV positive rates at 8-times the national average. Adolescents are the least likely group to know their HIV status and have the lowest rate of linka [....] » Read More

Speaker at Infection Conferences - Dongsheng Jiang
Oral Presentation (Virtual)
Dongsheng Jiang, Pennsylvania State University, United States

Lyme disease, the leading vector-borne illness in the United States, impacts roughly 476,000 individuals each year. As its geographical reach expands, healthcare providers face increasing hurdles in diagnosing and treating the disease, especially in its early stages. Despite bein [....] » Read More

Speaker at Infection Conference - Netty Santoso
Oral Presentation (Virtual)
Netty Santoso, Ohio State University, United States

Kaposi’s Sarcoma-associated herpes virus (KSHV), one of human gamma-herpesviruses, is a large double-stranded DNA virus that establishes long-term persistent infection. Primary infection of KSHV is usually asymptomatic, but its infection causes cancer under immunocompromise [....] » Read More

Speaker at Infectious Diseases Conferences - Arjun Chadha
Oral Presentation (Virtual)
Arjun Chadha, Michigan State University, United States

Syphilis is a venereal or vertically transmitted infectious disease caused by Treponema pallidum, a corkscrew shaped, motile spirochete. It generally progresses via stages and, if left untreated, can result in devastating cardiovascular and neurological sequelae. Ocular syphil [....] » Read More

Speaker at Infectious Diseases Conferences - Yuhang Liu
Oral Presentation (Virtual)
Yuhang Liu, Moderna Services, Inc., United States

During the initial outbreak of COVID-19, governments worldwide implemented various non-pharmaceutical interventions (NPIs) to help control the spread of the virus. Our study focused on assessing the impact of these interventions in the United States during the first wave of the p [....] » Read More

Speaker at Infectious Diseases Conference - Sira S. Owibingire
Oral Presentation (Virtual)
Sira S. Owibingire, School of Dentistry Muhimbili University, Tanzania, United Republic of

Background: There has been a global upsurge of oropharyngeal cancer (OPC) cases associated with increased human papillomavirus (HPV) infection. In Tanzania and Sub-Saharan African countries data on the same is lacking and HPV among OPC patients is not investigated routinely. The [....] » Read More

Speaker at Infectious Diseases Conferences - Britt Hornei
Oral Presentation (Virtual)
Britt Hornei, Institiut für Klinische Mikrobiologie und Labormedizin, Germany

The aim of the study is the clinical evaluation of an diagnostic marker system that is able to distinguish between bacterial and viral infection, with focus on the influences on therapeutic regimes in primary care and inpatient care. Material and Method: The MeMed- BV® Sco [....] » Read More

Watsapp